Champions Oncologysolid tumorsmyeloid modulators
…an TMEs and their influence on immune effector function.Methods Champions Oncology developed an ex vivo, patient-derived 3D co-culture system inco…
5articles mentioning institutions
9institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: Champions Oncology ×
Champions Oncology
This institution is selected. Its supporting articles are shown below.
Articles mentioning Champions Oncology
5 articles · page 1 of 1Champions Oncologybreast cancerstrastuzumab emtansinenon-small cell lung cancersstaurosporineHER2-targeting ADCsHER2-driven cancers
… components in a native-like tumor microenvironment.Conclusions Champions Oncology’s HER2-positive CTG3D PDXO platform provides a robust, translat…
Champions OncologyTaconic BiosciencesAcute myeloid leukemiaGM-CSFCAR-T cell therapiesAMLIL-3
… translational relevance.Methods To overcome these limitations, Champions Oncology and Taconic Biosciences developed a humanized in vivo AML platf…
Champions OncologytrastuzumabHER2-positive cancers
…y and therapeutic response in patients.Methods To address this, Champions Oncology developed a translational ADCC evaluation platform using patien…
Champions Oncology
…entifiers (UMIs) from <1,000 cells. We next adapted DRUG-seq to Champions Oncology’s CTG3D platform—a diverse biobank of patient-derived organoids…